Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$35,030,301
+$4,142,154 QoQ
Shares Held
139,208
-2.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#444
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $244,605,118 across 14 Drug Manufacturers - General names. ABBV ranks #4 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
210,285 | $53,406,081 | |
| 2 | LLY |
ELI LILLY & Co
|
37,094 | $44,491,660 | |
| 3 | MRK |
Merck & Co., Inc.
|
272,973 | $35,077,030 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
139,208 | $35,030,301 | |
| 5 | AMGN |
Amgen Inc
|
93,841 | $33,981,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
282,306 | $16,266,471 | |
| 7 | AZN |
Astrazeneca PLC
|
53,960 | $10,231,895 | |
| 8 | PFE |
Pfizer Inc
|
335,032 | $8,067,570 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,030,301 | 139,208 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $30,888,147 | 142,021 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $34,363,068 | 150,392 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $34,959,529 | 150,987 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $26,918,241 | 145,018 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $30,452,055 | 145,342 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $25,960,193 | 146,090 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $31,688,233 | 160,463 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $25,082,570 | 146,237 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $27,659,897 | 151,894 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,934,053 | 160,896 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $24,370,266 | 163,493 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $23,246,718 | 172,543 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $30,035,507 | 188,464 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $31,496,011 | 194,889 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,212,959 | 187,862 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $31,168,213 | 203,501 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $33,279,075 | 205,287 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $30,438,461 | 224,804 | Shares | Defined | 2022-03-07 | |
| 2021-09-30 | $29,244,851 | 271,112 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $30,811,996 | 273,544 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $28,476,361 | 263,134 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $27,365,574 | 255,395 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $22,455,448 | 256,370 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $25,520,712 | 259,938 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $19,561,096 | 256,741 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||